Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Biological Phenomena, Cell Phenomena, and Immunity (2)
- Cell Biology (2)
- Cell and Developmental Biology (2)
- Chemicals and Drugs (2)
- Diseases (2)
-
- Life Sciences (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Bioinformatics (1)
- Biological Factors (1)
- Cancer Biology (1)
- Chemical and Pharmacologic Phenomena (1)
- Circulatory and Respiratory Physiology (1)
- Equipment and Supplies (1)
- Investigative Techniques (1)
- Medical Cell Biology (1)
- Medical Specialties (1)
- Medicinal Chemistry and Pharmaceutics (1)
- Neoplasms (1)
- Pharmaceutical Preparations (1)
- Pharmacology, Toxicology and Environmental Health (1)
- Physiological Processes (1)
- Pulmonology (1)
- Respiratory Tract Diseases (1)
- Keyword
-
- Acetylation (1)
- Acetyltransferases (1)
- Alpha-Tocopherol (1)
- Antitoxins (1)
- Bacterial Toxins (1)
-
- Chemotherapeutic agents (1)
- Cytoprotection (1)
- Electronic Nicotine Delivery Systems (1)
- Escherichia coli Proteins (1)
- Humans (1)
- Ile (1)
- Lung Injury (1)
- Met (1)
- Nicotine (1)
- P53 (1)
- Post-Translational (1)
- Protein Biosynthesis (1)
- Protein Processing (1)
- Protein Processing, Post-Translational (1)
- RNA (1)
- RNA, Transfer, Ile (1)
- RNA, Transfer, Met (1)
- RRNA maturation (1)
- Ribosome (1)
- Tobacco Products (1)
- Toxicity (1)
- Transfer (1)
- Vaping (1)
- Vitamin E (1)
Articles 1 - 3 of 3
Full-Text Articles in Medical Toxicology
Utilizing Primary Human Airway Mucociliary Tissue Cultures To Model Ramifications Of Chronic E-Cigarette Usage., Vincent J Manna, Shannon Dwyer, Vanessa Pizutelli, Salvatore J Caradonna
Utilizing Primary Human Airway Mucociliary Tissue Cultures To Model Ramifications Of Chronic E-Cigarette Usage., Vincent J Manna, Shannon Dwyer, Vanessa Pizutelli, Salvatore J Caradonna
Rowan-Virtua School of Osteopathic Medicine Faculty Scholarship
Electronic cigarettes are battery powered devices that use a vape-liquid to produce a vapor that is inhaled. A consequence of the rise in e-cigarette usage was the 2019 emergence of a vaping-induced respiratory disease denoted as 'e-cigarette or vaping use-associated lung injury' (EVALI). One of the suspected causes of EVALI is Vitamin E Acetate (VEA), which was found to be a diluent in certain illicit vape-pens, whereas nicotine is commonly diluted in equal parts propylene glycol and vegetable glycerin (PG:VG). The prevalent use of e-cigarettes and the emergence of a novel illness has made understanding how e-cigarette vapors affect our …
Escherichia Coli Itat Is A Type Ii Toxin That Inhibits Translation By Acetylating Isoleucyl-Trnaile, Brendan Wilcox, Ilya Osterman, Marina Serebryakova, Dmitry Lukyanov, Ekaterina Komarova, Bridget Gollan, Natalia Morozova, Yuri I Wolf, Kira S Makarova, Sophie Helaine, Petr Sergiev, Svetlana Dubiley, Sergei Borukhov, Konstantin Severinov
Escherichia Coli Itat Is A Type Ii Toxin That Inhibits Translation By Acetylating Isoleucyl-Trnaile, Brendan Wilcox, Ilya Osterman, Marina Serebryakova, Dmitry Lukyanov, Ekaterina Komarova, Bridget Gollan, Natalia Morozova, Yuri I Wolf, Kira S Makarova, Sophie Helaine, Petr Sergiev, Svetlana Dubiley, Sergei Borukhov, Konstantin Severinov
Rowan-Virtua School of Osteopathic Medicine Faculty Scholarship
Prokaryotic toxin-antitoxin (TA) modules are highly abundant and are involved in stress response and drug tolerance. The most common type II TA modules consist of two interacting proteins. The type II toxins are diverse enzymes targeting various essential intracellular targets. The antitoxin binds to cognate toxin and inhibits its function. Recently, TA modules whose toxins are GNAT-family acetyltransferases were described. For two such systems, the target of acetylation was shown to be aminoacyl-tRNA: the TacT toxin targets aminoacylated elongator tRNAs, while AtaT targets the amino acid moiety of initiating tRNAMet. We show that the itaRT gene pair from Escherichia coli …
Targeting Ribosome Assembly Factors Selectively Protects P53 Positive Cells From Chemotherapeutic Agents, Russell T. Sapio, Anastasiya Nezdyur, Matthew Krevetski, Leonid Anikin, Vincent J. Manna, N. Minkovsky, Dimitri G Pestov
Targeting Ribosome Assembly Factors Selectively Protects P53 Positive Cells From Chemotherapeutic Agents, Russell T. Sapio, Anastasiya Nezdyur, Matthew Krevetski, Leonid Anikin, Vincent J. Manna, N. Minkovsky, Dimitri G Pestov
Rowan-Virtua School of Osteopathic Medicine Faculty Scholarship
Many chemotherapeutic agents act in a nondiscriminatory fashion, targeting both cancerous and noncancerous cells in Sphase and Mphase. One approach to reduce the toxic side effects in normal tissue is to exploit the differences in p53 functionality between cancerous and noncancerous cells. For example, activating p53 signaling by nongenotoxic means can transiently arrest noncancerous p53 positive cells in G1 phase and protect them from the cytotoxic effects of chemotherapeutic drugs. However, since most cancerous cells have faulty p53 signaling, they will proceed to cycle, and continue to be affected by the drug. In this study we asked if this G1‐phase …